The crosstalk of ER α with HER2 and the other members of the epithelial growth factor receptor (EGFR) family are well known, widely reported, and are commonly considered among the reasons responsible for breast cancer progression following the development of endocrine resistance [99,100,101]. Here, EGFR is linked to breast cancer.